| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3257329 | Clinical Immunology | 2011 | 12 Pages |
Abstract
⺠There are 2 major CD1d-restricted T cell populations ⺠Both CD1d-restricted T cell subsets can contribute to anti-tumor immunity ⺠Both CD1d-restricted T cell subsets can “lose” against progressive tumors ⺠Both CD1d-restricted T cell subsets defects can be reversed ⺠Improved CD1d-restricted T cell therapies are nearing clinical trials
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Mark A. Exley, Lydia Lynch, Bindu Varghese, Michael Nowak, Nadia Alatrakchi, Steven P. Balk,